000 02536ngm a2200577 a 4500
001 HST4211
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 160414s2016 enk|||||||||||s|||v|eng d
028 5 0 _a4211
_bHenry Stewart Talks
035 _a(UkLoHST)3242
040 _aUkLoHST
_beng
_cUkLoHST
100 1 _aMcDermott, David,
_u(Harvard Medical School, USA)
_4spk
245 1 0 _aImmune checkpoint blockade in renal cell carcinoma
_h[electronic resource] /
_cDavid McDermott.
260 _aLondon :
_bHenry Stewart Talks,
_c2016.
300 _a1 online resource (1 streaming video file (58 min.) :
_bcolor, sound).
490 1 _aImmunotherapy of cancer,
_x2056-452X
490 1 _aThe kidney in health and disease,
_x2056-452X
500 _aAnimated audio-visual presentation with synchronized narration.
500 _aTitle from title frames.
505 0 _aContents: Recent data that has led to the approval of PD-1 blockade in RCC -- Approaches to patient selection -- Novel combination therapies that are entering pivotal trials.
506 _aAccess restricted to subscribers.
538 _aMode of access: World Wide Web.
650 0 _aAntineoplastic agents.
650 0 _aCancer
_xImmunological aspects.
650 0 _aImmunotherapy.
650 0 _aKidneys
_xCancer
_xChemotherapy.
650 0 _aKidneys
_xCancer
_xImmunological aspects.
650 0 _aRenal cell carcinoma.
650 2 _aAntibodies, Monoclonal
_xtherapeutic use.
650 2 _aAntineoplastic Agents
_xtherapeutic use.
650 2 _aCarcinoma, Renal Cell
_xdrug therapy.
650 2 _aCarcinoma, Renal Cell
_ximmunology.
650 2 _aCell Cycle Checkpoints.
650 2 _aClinical Trials as Topic.
650 2 _aCombined Modality Therapy.
650 2 _aCTLA-4 Antigen
_ximmunology.
650 2 _aImmunotherapy
_xmethods.
650 2 _aKidney Neoplasms
_xdrug therapy.
650 2 _aKidney Neoplasms
_ximmunology.
650 2 _aPatient Selection.
650 2 _aProgrammed Cell Death 1 Receptor
_xantagonists & inhibitors.
650 2 _aT-Lymphocytes
_ximmunology.
830 0 _aHenry Stewart talks.
_pBiomedical & life sciences collection.
_pImmunotherapy of cancer.
830 0 _aHenry Stewart talks.
_pBiomedical & life sciences collection.
_pKidney in health and disease.
856 4 0 _uhttps://hstalks.com/bs/3242/
856 4 2 _uhttps://hstalks.com/bs/p/896/
_3Series (Immunotherapy of cancer)
856 4 2 _uhttps://hstalks.com/bs/p/980/
_3Series (Kidney in health and disease)
999 _c76721
_d76721